Bridgefront Capital, LLC Invitae Corp Transaction History

Bridgefront Capital, LLC

  • $129 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.13 - $9.01 $27,097 - $114,625
-12,722 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$6.28 - $15.59 $79,894 - $198,335
12,722 New
12,722 $101,000
Q1 2021

May 17, 2021
SELL
$33.06 - $56.93 $258,297 - $444,794
-7,813 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$39.09 - $57.4 $305,410 - $448,466
7,813 New
7,813 $327,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email